Proathlete Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$320K Buy
1,308
+1
+0.1% +$233 0.09% 52
2025
Q4
$271K Buy
1,307
+22
+2% +$4.35K 0.07% 54
2025
Q3
$238K Sell
1,285
-14
-1% -$2.4K 0.07% 57
2025
Q2
$199K Buy
1,299
+215
+20% +$33K 0.06% 59
2025
Q1
$180K Buy
+1,084
New +$170K 0.07% 62

Other funds holding JNJ

Proathlete Wealth Management's JNJ Position: Q1 2026 in Review

Proathlete Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.08% in Q1 2026, buying an estimated $233 and bringing the position to 1,308 shares worth $320K. The position accounts for 0.09% of the portfolio, ranked #52.

Proathlete Wealth Management first reported a position in JNJ in Q1 2025 and has held it in 5 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Proathlete Wealth Management held 1,308 shares of Johnson & Johnson worth $320K as of Q1 2026.
  • Proathlete Wealth Management bought 1 Johnson & Johnson share in Q1 2026, an estimated $233.
  • Johnson & Johnson made up 0.09% of Proathlete Wealth Management's portfolio in Q1 2026, its #52 holding.
  • Proathlete Wealth Management first reported a position in Johnson & Johnson in Q1 2025 and has held it in 5 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Proathlete Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.